Studying interplay between gut microbiome and cancer treatments to reduce cardiac complications
The treatment of cancer may soon get a shot in the arm as researchers come closer to understanding the link between the disease and the diversity of microbes, […]
Silencing RNA nanotherapy shows promise against pancreatic cancer
A Washington University-USF Health preclinical study finds that the novel nanoparticle delivers gene-level treatment to suppress KRAS-driven cancer without adverse effects Despite advances in cancer survival, more than […]
Hua Pan’s presentation wins a top prize at European Society of Cardiology Congress
USF Health’s Hua Pan, PhD, MBA, won first place for her moderated poster presentation titled “Anti-thrombin nanoparticles limit ischemia-reperfusion injury and no-reflow in myocardial infarction” on Sept. 2 […]
MCOM researchers part of study using new mouse model linking transfusions to dangerous digestive disease in infants
USF Health Heart Institute scientists developed nanoparticles deployed to suppress inflammation in the bowels of anemic infant mice, preventing transfusion-associated intestinal injury Physicians have long suspected that red […]
Nano-delivered therapy inhibits spread of ovarian, uterine cancer cells
The peptide-siRNA nanoparticle technology applied in the preclinical study was developed by USF Health Heart Institute researchers Advanced ovarian and uterine cancers are deadly diseases. Ovarian cancers, in […]
USF Health, Moffitt lead one of nation’s first academic Cardio-Oncology Programs
Michael Fradley, MD, had finished medical school. He’d completed training in internal medicine and cardiology. He decided to pursue further training in electrophysiology, and began observing a substantial […]
Pioneering nanotechnology research has applications for cardiovascular diseases
The founding director of the USF Health Heart Institute has a passion for innovation, translational medicine and entrepreneurship. Samuel A. Wickline, MD, has parlayed his expertise in harnessing […]